Compounded formulations are not the same as branded equivalents, but they contain the same active pharmaceutical ingredients made to USP standards
R: A Language and Environment for Statistical Computing version 4.0.2
GHK-Cu (100 mg) is a synthetic research peptide complex in the healing and regenerative research category
For some individuals, lithium is the best treatment, considered a lifesaver for some, even though it has a host of likely side effects, says Varin
Each production batch is manufactured to exceed 99% purity and tested using HPLC and LC-MS analytical protocols to support peptide identity, purity evaluation, and batch-to-batch consistency
Reported side effects (minimal) Common experience: Very well-tolerated (most users report zero sides) Decades of Russian use without serious issues Dipeptide (just 2 amino acids) = low immunogenicity Occasional mild effects: Injection site reactions : Redness, slight swelling (normal) Mild headache first 1-2 days (rare) Fatigue or drowsiness (uncommon) No major side effects reported What Cartalax does NOT cause: No GI upset (unlike NSAIDs ) No systemic effects (tissue-specific) No hormonal disruption No dependency or withdrawal Generally very safe Long-term safety: Russian use 30+ years No serious adverse events documented Cyclic use pattern reduces continuous exposure Bioregulator approach inherently safer Well-established safety profile Contraindications: Pregnancy / breastfeeding (not studied) Active cancer (theoretical growth factor concern) Severe immune dysfunction (unknown effects) Otherwise: Generally safe Monitoring recommendations Before starting: Baseline joint function assessment Note pain levels, mobility, stiffness Take progress photos if visible swelling Document current medications Blood work (optional, for comprehensive baseline) During cycles: Track daily subjective joint feelings Note any side effects Pain scale tracking (1-10) Mobility changes Overall quality of life After cycles: Reassess joint function monthly Compare to baseline Determine cycle frequency needed Adjust protocol based on response Patient long-term approach When to discontinue: Any severe reactions (extremely rare) No benefit after 2-3 cycles Unacceptable side effects Medical concerns arise Alternative treatment preferred See peptide safety and risks comprehensive guide
